X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4560) 4560
Book Review (621) 621
Publication (338) 338
Newsletter (42) 42
Book Chapter (21) 21
Conference Proceeding (17) 17
Magazine Article (4) 4
Newspaper Article (4) 4
Dissertation (2) 2
Book / eBook (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3879) 3879
humans (2731) 2731
proline - analogs & derivatives (1659) 1659
animals (1657) 1657
male (1497) 1497
proline (1366) 1366
female (1138) 1138
middle aged (771) 771
captopril - therapeutic use (753) 753
adult (707) 707
rats (619) 619
mice (595) 595
proteins (591) 591
biochemistry & molecular biology (588) 588
proline - therapeutic use (562) 562
pharmacology & pharmacy (541) 541
hypertension - drug therapy (495) 495
analysis (473) 473
aged (434) 434
antiviral agents - therapeutic use (382) 382
abridged index medicus (371) 371
drug therapy, combination (366) 366
oligopeptides - therapeutic use (358) 358
peptides (355) 355
blood pressure - drug effects (353) 353
cell biology (335) 335
hepatitis c, chronic - drug therapy (318) 318
proline - pharmacology (315) 315
multidisciplinary sciences (309) 309
amino acids (306) 306
enzymes (304) 304
research (299) 299
research article (296) 296
medicine (292) 292
cancer (286) 286
article (275) 275
proline - metabolism (275) 275
physiological aspects (271) 271
health aspects (260) 260
expression (257) 257
time factors (253) 253
metabolism (251) 251
renin - blood (248) 248
gene expression (242) 242
neurosciences (241) 241
science (238) 238
amino acid sequence (234) 234
gastroenterology & hepatology (221) 221
proline - chemistry (220) 220
ribavirin - therapeutic use (219) 219
dose-response relationship, drug (218) 218
disease models, animal (217) 217
apoptosis (215) 215
genotype (213) 213
signal transduction (209) 209
hypoxia (208) 208
treatment outcome (207) 207
biochemistry (205) 205
hepacivirus - genetics (204) 204
angiotensin-converting enzyme inhibitors (202) 202
captopril - adverse effects (202) 202
oncology (202) 202
interferon-alpha - therapeutic use (201) 201
genetic aspects (200) 200
hepatitis c (198) 198
protein binding (193) 193
cell line, tumor (192) 192
heart failure - drug therapy (192) 192
biology (185) 185
care and treatment (185) 185
boceprevir (184) 184
captopril - pharmacology (184) 184
rodents (181) 181
molecular sequence data (179) 179
telaprevir (179) 179
life sciences (178) 178
activation (176) 176
collagen (172) 172
mutation (172) 172
phosphorylation (172) 172
cells, cultured (170) 170
chemistry, medicinal (170) 170
hepatitis c virus (170) 170
cells (169) 169
immunology (169) 169
hemodynamics - drug effects (167) 167
oxidative stress (163) 163
procollagen-proline dioxygenase - metabolism (163) 163
models, molecular (159) 159
polyethylene glycols - therapeutic use (159) 159
inflammation (158) 158
kinases (157) 157
biochemistry, general (156) 156
protease inhibitors - therapeutic use (156) 156
protein (155) 155
protease inhibitors (153) 153
physiology (151) 151
hepacivirus - drug effects (150) 150
kinetics (149) 149
biophysics (148) 148
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4343) 4343
French (61) 61
German (56) 56
Japanese (38) 38
Italian (25) 25
Russian (20) 20
Spanish (17) 17
Portuguese (16) 16
Chinese (9) 9
Polish (9) 9
Hebrew (6) 6
Hungarian (6) 6
Danish (5) 5
Swedish (4) 4
Dutch (3) 3
Czech (2) 2
Finnish (2) 2
Serbian (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 13, pp. 1207 - 1217
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 147, Issue 1, pp. 132 - 142.e4
Background & Aims We investigated the effectiveness of the protease inhibitors peginterferon and ribavirin in treatment-experienced patients with hepatitis C... 
Gastroenterology and Hepatology | Triple Therapy | Chronic Hepatitis C | DAA | CUPIC | LONG-TERM | RISK-FACTORS | CHRONIC HEPATITIS-C | RIBAVIRIN | COMPENSATED CIRRHOSIS | NATURAL-HISTORY | PEGINTERFERON | SUSTAINED VIROLOGICAL RESPONSE | PLUS SOFOSBUVIR | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT FAILURE | Recombinant Proteins - therapeutic use | Multivariate Analysis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Liver Cirrhosis - epidemiology | Treatment Failure | Aged, 80 and over | Adult | Female | Hepatitis C, Chronic - epidemiology | Drug Therapy, Combination | Liver Cirrhosis - drug therapy | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Comorbidity | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Proline - therapeutic use | Liver Cirrhosis - virology | Antiviral Agents - adverse effects | Proline - adverse effects | Aged | Cohort Studies | Care and treatment | Protease inhibitors | Proteases | Genetic aspects | Hepatitis C virus | Hepatitis C | Health aspects | Liver cirrhosis | Index Medicus | Abridged Index Medicus
Journal Article
Hepatology, ISSN 0270-9139, 2008, Volume 48, Issue 6, pp. 1769 - 1778
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9742, pp. 705 - 716
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 13, pp. 1195 - 1206
Journal Article
Gastroenterology, ISSN 0016-5085, 2013, Volume 144, Issue 7, pp. 1450 - 1455.e2
Journal Article